From December 31, 2022 to March 13, 2023, the company has repurchased 2,921,200 shares, representing 0.26% for CNY 100.97 million. With this, the company has completed the repurchase of 3,581,600 shares, representing 0.32% for CNY 120.97 million under the buyback announced on October 12, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
20.81 CNY | -2.44% | +3.02% | -23.35% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.35% | 3.22B | |
-2.35% | 89.08B | |
+3.55% | 40.9B | |
-14.40% | 32.25B | |
+55.01% | 25.14B | |
-15.96% | 15.39B | |
-15.50% | 11.91B | |
-41.29% | 11.89B | |
-11.75% | 11.64B | |
+6.59% | 9.03B |
- Stock Market
- Equities
- 300601 Stock
- News Shenzhen Kangtai Biological Products Co., Ltd.
- Tranche Update on Shenzhen Kangtai Biological Products Co., Ltd.'s Equity Buyback Plan announced on October 12, 2022.